symbol,statement_type,period_end,line_item,value
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-1114554000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,4891034000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-2436340000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,End Cash Position,285237000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,2000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,317560000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,10200000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-42525000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,626537000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-767264000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,4891034000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,4891034000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-3491709000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,-538722000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-2952987000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-1990848000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,1000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,80522000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,9392000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,80526000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Sale Of Business,80526000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-2161289000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,275051000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-2436340000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,1321786000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-470227000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-1381751000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,545327000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-449996000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-699444000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-223156000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-554482000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,576254000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,63430000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,1129925000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Depreciation,1129925000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-41424000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-43068000.0
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of Business,
SHILPAMED.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,1223329000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-478914000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,0.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-1845605000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,End Cash Position,317560000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,190714000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,-41750000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,168596000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,467749000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-1000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-923690000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,0.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,0.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,1396718000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,163711000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,1233007000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-1665844000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,120985000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,13840000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,0.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-65064000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,110000000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Sale Of Business,110000000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,-65064000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-1724620000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,120985000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-1845605000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,1366691000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-411890000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-672471000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-58540000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-90487000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Change In Payable,343272000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-107729000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-758987000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,889218000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,26099000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,1078699000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Depreciation,1078699000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-72048000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,8530000.0
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of Business,
SHILPAMED.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,543407000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-467438000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,0.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-2266674000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,End Cash Position,190714000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,256223000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,3397000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-68906000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,457980000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,1000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-579191000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-95482000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,0.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,1138094000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,1412623000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-274529000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-2326122000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,12087000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,12762000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,5000000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-89297000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,-89297000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Sale Of Business,0.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,-89297000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-2266674000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,12087000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-2266674000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,1799236000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-323748000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,1027705000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-21993000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,68117000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-23228000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,354173000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,650636000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,560725000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,60297000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,954990000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Depreciation,954990000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,2648000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-40639000.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of Business,0.0
SHILPAMED.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,-382795000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-2266928000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,2968396000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-3318261000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,End Cash Position,253390000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,1228457000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-975068000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,828583000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,-1000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-413798000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-89680000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-89680000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,2968396000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,2968396000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-1630498000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,-415572000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-1214926000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-2854984000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,316359000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,20142000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,10002000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-173464000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,284127000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Sale Of Business,284127000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,0.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-3312150000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,6111000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-3318261000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,1051333000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-344827000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-719912000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,312627000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,196929000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Change In Payable,837257000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-384010000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-1682715000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,376881000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,0.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,798019000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Depreciation,798019000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,16022000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-37970000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of Business,-87911000.0
SHILPAMED.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,1022648000.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,-1432000.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,0.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,4847000.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Sale Of Business,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,-624393000.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Depreciation,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of Business,-608400000.0
SHILPAMED.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
